MARKET

IMRN

IMRN

Immuron Ltd
NASDAQ
0.8800
+0.0488
+5.87%
Pre Market: 0.8700 -0.01 -1.14% 05:15 11/10 EST
OPEN
0.8200
PREV CLOSE
0.8312
HIGH
0.8950
LOW
0.8200
VOLUME
69
TURNOVER
0
52 WEEK HIGH
1.990
52 WEEK LOW
0.6765
MARKET CAP
7.10M
P/E (TTM)
-2.5671
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMRN last week (1102-1106)?
Weekly Report · 1d ago
Emerging Growth Research Reports Continued Revenue Growth at Immuron
Barchart · 5d ago
Weekly Report: what happened at IMRN last week (1026-1030)?
Weekly Report · 11/02 10:03
Immuron Limited Announces Strategic Reset to Partner Clinical Assets and Reports FY26 Global Sales Revenue of $7.7m
NASDAQ · 10/28 17:41
Immuron Limited Announces Q1 Global Sales of AUD$2.2 million
NASDAQ · 10/27 15:11
Weekly Report: what happened at IMRN last week (1019-1023)?
Weekly Report · 10/26 10:03
Immuron Cuts U.S. ATM Offering Capacity to $2 Million in Updated F-3 Filing
TipRanks · 10/23 21:47
Weekly Report: what happened at IMRN last week (1012-1016)?
Weekly Report · 10/19 10:03
More
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.

Webull offers Immuron Ltd - ADR stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.